These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18684921)

  • 1. Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner.
    Mars LT; Gautron AS; Novak J; Beaudoin L; Diana J; Liblau RS; Lehuen A
    J Immunol; 2008 Aug; 181(4):2321-9. PubMed ID: 18684921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice.
    Falcone M; Facciotti F; Ghidoli N; Monti P; Olivieri S; Zaccagnino L; Bonifacio E; Casorati G; Sanvito F; Sarvetnick N
    J Immunol; 2004 May; 172(10):5908-16. PubMed ID: 15128771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interdependency of MHC class II/self-peptide and CD1d/self-glycolipid presentation by TNF-matured dendritic cells for protection from autoimmunity.
    Wiethe C; Schiemann M; Busch D; Haeberle L; Kopf M; Schuler G; Lutz MB
    J Immunol; 2007 Apr; 178(8):4908-16. PubMed ID: 17404272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice.
    Mars LT; Laloux V; Goude K; Desbois S; Saoudi A; Van Kaer L; Lassmann H; Herbelin A; Lehuen A; Liblau RS
    J Immunol; 2002 Jun; 168(12):6007-11. PubMed ID: 12055208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cell-type specific CD1d expression program modulates invariant NKT cell development and function.
    Zimmer MI; Colmone A; Felio K; Xu H; Ma A; Wang CR
    J Immunol; 2006 Feb; 176(3):1421-30. PubMed ID: 16424169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.
    Miyamoto K; Miyake S; Yamamura T
    Nature; 2001 Oct; 413(6855):531-4. PubMed ID: 11586362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.
    Jahng A; Maricic I; Aguilera C; Cardell S; Halder RC; Kumar V
    J Exp Med; 2004 Apr; 199(7):947-57. PubMed ID: 15051763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD1d-independent NKT cells in beta 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells.
    Maeda M; Shadeo A; MacFadyen AM; Takei F
    J Immunol; 2004 May; 172(10):6115-22. PubMed ID: 15128797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.
    Singh AK; Wilson MT; Hong S; Olivares-Villagómez D; Du C; Stanic AK; Joyce S; Sriram S; Koezuka Y; Van Kaer L
    J Exp Med; 2001 Dec; 194(12):1801-11. PubMed ID: 11748281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity.
    Oh K; Kim S; Park SH; Gu H; Roopenian D; Chung DH; Kim YS; Lee DS
    J Immunol; 2005 Feb; 174(4):2030-6. PubMed ID: 15699132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells.
    Pellicci DG; Hammond KJ; Coquet J; Kyparissoudis K; Brooks AG; Kedzierska K; Keating R; Turner S; Berzins S; Smyth MJ; Godfrey DI
    J Immunol; 2005 Oct; 175(7):4416-25. PubMed ID: 16177083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance.
    Faunce DE; Stein-Streilein J
    J Immunol; 2002 Jul; 169(1):31-8. PubMed ID: 12077225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells.
    Thomas SY; Hou R; Boyson JE; Means TK; Hess C; Olson DP; Strominger JL; Brenner MB; Gumperz JE; Wilson SB; Luster AD
    J Immunol; 2003 Sep; 171(5):2571-80. PubMed ID: 12928408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD1d under the control of a MHC class Ia promoter skews the development of NKT cells, but not CD8+ T cells.
    Xu H; Chun T; Colmone A; Nguyen H; Wang CR
    J Immunol; 2003 Oct; 171(8):4105-12. PubMed ID: 14530332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
    Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
    J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human NKT cells express granulysin and exhibit antimycobacterial activity.
    Gansert JL; Kiessler V; Engele M; Wittke F; Röllinghoff M; Krensky AM; Porcelli SA; Modlin RL; Stenger S
    J Immunol; 2003 Mar; 170(6):3154-61. PubMed ID: 12626573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells.
    Ajuebor MN; Aspinall AI; Zhou F; Le T; Yang Y; Urbanski SJ; Sidobre S; Kronenberg M; Hogaboam CM; Swain MG
    J Immunol; 2005 Jun; 174(12):8027-37. PubMed ID: 15944310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR.
    Grubor-Bauk B; Simmons A; Mayrhofer G; Speck PG
    J Immunol; 2003 Feb; 170(3):1430-4. PubMed ID: 12538704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.